Recombinant Human CC16 Protein，His

CC16, also known as Clara Cell Protein 16, is a lung-specific protein predominantly secreted by Clara cells in the airway epithelium. It plays a crucial role in pulmonary function and has been implicated in various respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Research into CC16 has gained momentum due to its potential as a biomarker for lung health and disease. Elevated or decreased levels of CC16 in serum or bronchoalveolar lavage fluid can indicate inflammatory processes or damage to the airways. Studies have shown that CC16 possesses anti-inflammatory and antioxidant properties, suggesting its protective role against airway injury. Moreover, CC16 has been explored as a therapeutic target, with the aim of modulating its levels to ameliorate lung diseases. Recent advancements in recombinant technology have enabled the production of CC16 as a recombinant protein, facilitating more detailed studies on its biological functions and mechanisms. These studies are crucial for understanding the pathophysiology of lung diseases and developing novel diagnostic and therapeutic strategies. Investigating CC16's structure, function, and interactions at the molecular level is essential to unlocking its potential in clinical applications and enhancing lung disease management.